Carola B.
- Country
- Germany
- Department
- Department of Dermatology
Research Overview
- A Phase 3, Randomized, Double-blind, Active-Comparator-Controlled Clinical Study of Adjuvant MK-7684A (Vibostolimab with Pembrolizumab) Versus Adjuvant Pembrolizumab in Participants with High-risk Stage II-IV Melanoma (KEYVIBE-010)
- Phase 4 Study on Incidence of Squamous Cell Carcinoma and Long-term Safety of Tirbanibulin Ointment and Diclofenac Sodium Gel in Actinic Keratosis
- Phase 3 Randomized Double-Blind Trial of Nivolumab and Relatlimab Versus Nivolumab Monotherapy in Stage III-IV Melanoma Post-Resection
Data & Insights
Has run more than one trial at 60 of 137 partner sites.
Specializations
Melanoma Research
This investigator specializes in advanced melanoma treatment, with particular emphasis on immunotherapy approaches for stages III and IV of the disease. Their work encompasses both adjuvant therapy and management of high-risk resected cases.
- Stage III-IV Melanoma Management
- Post-Surgical Treatment Strategies
- Immunotherapy Combinations
The research extends to evaluating novel therapeutic combinations and comparative treatment outcomes in melanoma patients.
Skin Cancer Therapeutics
The investigator focuses on developing treatments for various forms of skin cancer, including innovative approaches for basal cell carcinoma. Their expertise includes evaluating novel therapeutic agents for advanced cases.
- Advanced Basal Cell Carcinoma
- First-line Treatment Protocols
- Treatment Response Assessment
Their work encompasses evaluation of targeted therapies and immune checkpoint inhibitors in skin cancer treatment.
Pre-Cancerous Conditions
The investigator conducts research in the treatment of actinic keratosis, focusing on preventive approaches and long-term management strategies. Their work includes comparative studies of topical treatments and safety monitoring.
- Topical Treatment Evaluation
- Long-term Safety Assessment
- Preventive Interventions
Research includes monitoring treatment outcomes and investigating progression to invasive carcinoma.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.